Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study

Erstveröffentlichung

2014

Authors

Joka, Mareile

Boeck, Stefan

Zech, Christoph J.

Seufferlein, Thomas

von Wichert, Goetz

et al.

Wissenschaftlicher Artikel

Published in

Anti-cancer drugs ; 25 (2014), 9. - S. 1095-1101. - ISSN 0959-4973. - eISSN 1473-5741

Link to publication

https://dx.doi.org/10.1097/CAD.0000000000000146

Institutions

UKU. Klinik für Innere Medizin I

Subject headings

[Free subject headings]: dose finding | everolimus | gemcitabine | locally advanced and/or metastatic pancreatic cancer | safety | PHASE-III | MAMMALIAN TARGET | EFFICACY | TRIAL | BEVACIZUMAB | CARCINOMA | PATHWAY | PLACEBO | RAD001
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record